KAI1 COOH-Terminal interacting tetraspanin (KITENIN) expression in early and advanced laryngeal cancer

Laryngoscope

Volumn 120, Issue 5, 2010, Pages 953-958

  Lee, Joon Kyoo ^a   Yoon, Tae Mi ^a   Seo, Deok Jung ^a   Sun, Eun Gene ^b   Bae, Jeong A ^b   Lim, Sang Chul ^a   Choi, Yoo Duk ^b   Lee, Jae Hyuk ^b   Joo, Young Eun ^b   Kim, Kyung Keun ^b  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

KAI1 COOH terminal interacting tetraspanin (KITENIN); Laryngeal neoplasms

Indexed keywords

CARBOXYLIC ACID; CD82 ANTIGEN; TETRASPANIN;

ADULT; ADVANCED CANCER; AGE; AGE DISTRIBUTION; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE FREE SURVIVAL; EARLY CANCER; FEMALE; GENDER; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LARYNX MUCOSA; LYMPH NODE METASTASIS; MALE; MEDICAL RECORD; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SQUAMOUS CELL CARCINOMA; STAINING; SURVIVAL RATE; WESTERN BLOTTING;

AGED; BIOPSY; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LARYNGEAL NEOPLASMS; LARYNX; LYMPHATIC METASTASIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77951723808     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20864     Document Type: Article

References (20)

1. Howell GM, Grandis JR. Molecular mediators of metastasis in head and neck squamous cell carcinoma. Head Neck 2005;27:710-717. (Pubitemid 41113773)
2. Jackson P, Marreiros A, Russell PJ. KAI1 tetraspanin and metastasis suppressor. Int J Biochem Cell Biol 2005;37:530-534.
3. Takaoka A, Hinoda Y, Satoh S, et al. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene. Oncogene 1998;16:1443-1453. (Pubitemid 28151851)
4. Yang JL, Jackson P, Yu Y, et al. Invasion and metastasis correlate with down-regulation of KAI1 expression in human colon cancer cell lines. GI Cancer 2001;3:313-322. (Pubitemid 34059345)
5. Yang X, Wei LL, Tang C, et al. Over-expression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. Cancer Res 2001;61:5284-5288. (Pubitemid 32681565)
6. Jee B, Jin K, Han JH, et al. Metastasis-suppressor KAI1/CD82 induces homotypic aggregation of human prostate cancer cells through a Src-dependent pathway. Exp Mol Med 2003;35:30-37. (Pubitemid 36336926)
7. Lee JH, Seo YW, Park SR, et al. Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression. Cancer Res 2003;63:7247-7255.
8. Lee JH, Park SR, Chay KO, et al. KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer. Cancer Res 2004;64:4235-4243.
9. Yagyu R, Hamamoto R, Furukawa Y, et al. Isolation and characterization of a novel human gene, VANGL1, as a therapeutic target for hepatocellular carcinoma. Int J Oncol 2002;20:1173-1178.
10. Lee JH, Cho ES, Kim MY, et al. Suppression of progression and metastasis of established colon tumors in mice by intravenous delivery of short interfering RNA targeting KITENIN, a metastasis-enhancing protein. Cancer Res 2005;65:8993-9003.
11. Kho DH, Bae JA, Lee JH, et al. KITENIN recruits Dishevelled/PKCd to form a functional complex and controls the migration and invasiveness of colorectal cancer cells. Gut 2009;58:509-519.
12. Lee JK, Bae JA, Sun EG, et al. KITENIN increases invasion and migration of mouse squamous cancer cells and promotes pulmonary metastasis in a mouse squamous tumor model. FEBS Lett 2009;583:711-717.
13. Dong JT, Lamb PW, Rinker-Schaeffer CW, et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995;268:884-886.
14. Rubinstein E, Naour FL, Laguadriere-Gesbert C, et al. CD9, CD63, CD81 and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA antigens. Eur J Immunol 1996;26:2657-2665. (Pubitemid 26364842)
15. Rowe A, Jackson P. Expression of KITENIN, a KAI1/CD82 binding protein and metastasis enhancer, in bladder cancer cell lines: relationship to KAI1/CD82 levels and invasive behaviour. Oncol Rep 2006;16:1267-1272.
16. Maurizi M, Scambia G, Benedetti Panici P, et al. EGF receptor expression in primary laryngeal cancer: correlation with clinico-pathological features and prognostic significance. Int J Cancer 1992;52:862-866. (Pubitemid 23009499)
17. Maurizi M, Almadori G, Ferrandina G, et al. Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer 1996;74:1253-1257. (Pubitemid 26360115)
18. Almadori G, Cadoni G, Galli J, et al. Epidermal growth factor receptor expression in primary laryngeal cancer: an independent prognostic factor of neck node relapse. Int J Cancer 1999;84:188-191. (Pubitemid 29133831)
19. Rubin Grandis J, Melhem MF, Gooding WE, et al. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 1998;90:824-832. (Pubitemid 28280548)
20. Wen QH, Miwa T, Yoshizaki T, et al. Prognostic value of EGFR and TGF-alpha in early laryngeal cancer treated with radiotherapy. Laryngoscope 1996;106:884-888. (Pubitemid 26242129)